Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Dec 1;100(11):2833–2841. doi: 10.1172/JCI119831

Deficiency of phosphofructo-1-kinase/muscle subtype in humans impairs insulin secretion and causes insulin resistance.

M Ristow 1, M Vorgerd 1, M Möhlig 1, H Schatz 1, A Pfeiffer 1
PMCID: PMC508489  PMID: 9389749

Abstract

Non-insulin-dependent diabetes mellitus (NIDDM) is caused by peripheral insulin resistance and impaired beta cell function. Phosphofructo-1-kinase (PFK1) is a rate-limiting enzyme in glycolysis, and its muscle subtype (PFK1-M) deficiency leads to the autosomal recessively inherited glycogenosis type VII Tarui's disease. It was evaluated whether PFK1-M deficiency leads to alterations in insulin action or secretion in humans. A core family of four members was evaluated for PFK1-M deficiency by DNA and enzyme-activity analyses. All members underwent oral and intravenous glucose tolerance tests (oGTT and ivGTT) and an insulin-sensitivity test (IST) using octreotide. Enzyme activity determinations in red blood cells showed that the father (46 yr, body mass index [BMI] 22. 4 kg/m2) and older son (19 yr, BMI 17.8 kg/m2) had a homozygous, while the mother (47 yr, BMI 28.4 kg/m2) and younger son (13 yr, BMI 16.5 kg/m2) had a heterozygous PFK1-M deficiency. DNA analyses revealed an exon 5 missense mutation causing missplicing of one allele in all four family members, and an exon 22 frameshift mutation of the other allele of the two homozygously affected individuals. The father showed impaired glucose tolerance, and the mother showed NIDDM. By ivGTT, both parents and the older son had decreased first-phase insulin secretion and a diminished glucose disappearance rate. The IST showed marked insulin resistance in both parents and the older, homozygous son, and moderate resistance in the younger son. PFK1-M deficiency causes impaired insulin secretion in response to glucose, demonstrating its participation in islet glucose metabolism, and peripheral insulin resistance. These combined metabolic sequelae of PFK-1 deficiency identify it as a candidate gene predisposing to NIDDM.

Full Text

The Full Text of this article is available as a PDF (342.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartlett D. L., Charland S. L., Torosian M. H. Reversal of tumor-associated hyperglucagonemia as treatment for cancer cachexia. Surgery. 1995 Jul;118(1):87–97. doi: 10.1016/s0039-6060(05)80014-5. [DOI] [PubMed] [Google Scholar]
  2. Bauer W., Briner U., Doepfner W., Haller R., Huguenin R., Marbach P., Petcher T. J., Pless SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci. 1982 Sep 13;31(11):1133–1140. doi: 10.1016/0024-3205(82)90087-x. [DOI] [PubMed] [Google Scholar]
  3. Baule G. M., Onorato D., Tola G., Forteleoni G., Meloni T. Hemoglobin A1 in subjects with G-6-PD deficiency during and after hemolytic crises due to favism. Acta Haematol. 1983;69(1):15–18. doi: 10.1159/000206832. [DOI] [PubMed] [Google Scholar]
  4. Beutler E., Blume K. G., Kaplan J. C., Löhr G. W., Ramot B., Valentine W. N. International Committee for Standardization in Haematology: recommended methods for red-cell enzyme analysis. Br J Haematol. 1977 Feb;35(2):331–340. doi: 10.1111/j.1365-2141.1977.tb00589.x. [DOI] [PubMed] [Google Scholar]
  5. Bogardus C., Lillioja S., Howard B. V., Reaven G., Mott D. Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. J Clin Invest. 1984 Oct;74(4):1238–1246. doi: 10.1172/JCI111533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bonilla E., Schotland D. L. Histochemical diagnosis of muscle phosphofructokinase deficiency. Arch Neurol. 1970 Jan;22(1):8–12. doi: 10.1001/archneur.1970.00480190012002. [DOI] [PubMed] [Google Scholar]
  7. Brunzell J. D., Robertson R. P., Lerner R. L., Hazzard W. R., Ensinck J. W., Bierman E. L., Porte D., Jr Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab. 1976 Feb;42(2):222–229. doi: 10.1210/jcem-42-2-222. [DOI] [PubMed] [Google Scholar]
  8. Chiu K. C., Province M. A., Permutt M. A. Glucokinase gene is genetic marker for NIDDM in American blacks. Diabetes. 1992 Jul;41(7):843–849. doi: 10.2337/diab.41.7.843. [DOI] [PubMed] [Google Scholar]
  9. Crockford P. M., Harbeck R. J., Williams R. H. Influence of age on intravenous glucose tolerance and serum immunoreactive insulin. Lancet. 1966 Feb 26;1(7435):465–467. doi: 10.1016/s0140-6736(66)91462-0. [DOI] [PubMed] [Google Scholar]
  10. DeFronzo R. A., Bonadonna R. C., Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care. 1992 Mar;15(3):318–368. doi: 10.2337/diacare.15.3.318. [DOI] [PubMed] [Google Scholar]
  11. DeFronzo R. A. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes. 1988 Jun;37(6):667–687. doi: 10.2337/diab.37.6.667. [DOI] [PubMed] [Google Scholar]
  12. Di Mauro S., Angelini C., Catani C. Enzymes of the glycogen cycle and glycolysis in various human neuromuscular disorders. J Neurol Neurosurg Psychiatry. 1967 Oct;30(5):411–415. doi: 10.1136/jnnp.30.5.411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dunaway G. A., Kasten T. P., Sebo T., Trapp R. Analysis of the phosphofructokinase subunits and isoenzymes in human tissues. Biochem J. 1988 May 1;251(3):677–683. doi: 10.1042/bj2510677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Goldhammer A. R., Paradies H. H. Phosphofructokinase: structure and function. Curr Top Cell Regul. 1979;15:109–141. [PubMed] [Google Scholar]
  15. Granner D. K., O'Brien R. M. Molecular physiology and genetics of NIDDM. Importance of metabolic staging. Diabetes Care. 1992 Mar;15(3):369–395. doi: 10.2337/diacare.15.3.369. [DOI] [PubMed] [Google Scholar]
  16. Greenfield M. S., Doberne L., Kraemer F., Tobey T., Reaven G. Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes. 1981 May;30(5):387–392. doi: 10.2337/diab.30.5.387. [DOI] [PubMed] [Google Scholar]
  17. Groop L. C., Kankuri M., Schalin-Jäntti C., Ekstrand A., Nikula-Ijäs P., Widén E., Kuismanen E., Eriksson J., Franssila-Kallunki A., Saloranta C. Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med. 1993 Jan 7;328(1):10–14. doi: 10.1056/NEJM199301073280102. [DOI] [PubMed] [Google Scholar]
  18. Groop L. C., Widén E., Ferrannini E. Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods? Diabetologia. 1993 Dec;36(12):1326–1331. doi: 10.1007/BF00400814. [DOI] [PubMed] [Google Scholar]
  19. Hager J., Hansen L., Vaisse C., Vionnet N., Philippi A., Poller W., Velho G., Carcassi C., Contu L., Julier C. A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus. Nat Genet. 1995 Mar;9(3):299–304. doi: 10.1038/ng0395-299. [DOI] [PubMed] [Google Scholar]
  20. Hales C. N. The pathogenesis of NIDDM. Diabetologia. 1994 Sep;37 (Suppl 2):S162–S168. doi: 10.1007/BF00400840. [DOI] [PubMed] [Google Scholar]
  21. Haller R. G., Lewis S. F. Glucose-induced exertional fatigue in muscle phosphofructokinase deficiency. N Engl J Med. 1991 Feb 7;324(6):364–369. doi: 10.1056/NEJM199102073240603. [DOI] [PubMed] [Google Scholar]
  22. Kadowaki T., Sakura H., Otabe S., Yasuda K., Kadowaki H., Mori Y., Hagura R., Akanuma Y., Yazaki Y. A subtype of diabetes mellitus associated with a mutation in the mitochondrial gene. Muscle Nerve Suppl. 1995;3:S137–S141. doi: 10.1002/mus.880181427. [DOI] [PubMed] [Google Scholar]
  23. Kahn C. R. Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes. 1994 Aug;43(8):1066–1084. doi: 10.2337/diab.43.8.1066. [DOI] [PubMed] [Google Scholar]
  24. Katz A., Spencer M. K., Lillioja S., Yan Z., Mott D. M., Haller R. G., Lewis S. F. Basal and insulin-mediated carbohydrate metabolism in human muscle deficient in phosphofructokinase 1. Am J Physiol. 1991 Oct;261(4 Pt 1):E473–E478. doi: 10.1152/ajpendo.1991.261.4.E473. [DOI] [PubMed] [Google Scholar]
  25. Layzer R. B., Rowland L. P., Ranney H. M. Muscle phosphofructokinase deficiency. Arch Neurol. 1967 Nov;17(5):512–523. doi: 10.1001/archneur.1967.00470290066009. [DOI] [PubMed] [Google Scholar]
  26. Malaisse W. J., Malaisse-Lagae F., Sener A., van Schaftingen E., Hers H. G. Is the glucose-induced stimulation of glycolysis in pancreatic islets attributable to activation of phosphofructokinase by fructose 2,6-bisphosphate? FEBS Lett. 1981 Mar 23;125(2):217–219. doi: 10.1016/0014-5793(81)80722-3. [DOI] [PubMed] [Google Scholar]
  27. Mimura A., Kageyama S., Maruyama M., Ikeda Y., Isogai Y. Insulin sensitivity test using a somatostatin analogue, octreotide (Sandostatin). Horm Metab Res. 1994 Apr;26(4):184–187. doi: 10.1055/s-2007-1000808. [DOI] [PubMed] [Google Scholar]
  28. Noda K., Matsutani A., Tanizawa Y., Neuman R., Kaneko T., Permutt M. A., Kaku K. Polymorphic microsatellite repeat markers at the glucokinase gene locus are positively associated with NIDDM in Japanese. Diabetes. 1993 Aug;42(8):1147–1152. doi: 10.2337/diab.42.8.1147. [DOI] [PubMed] [Google Scholar]
  29. Pei D., Jones C. N., Bhargava R., Chen Y. D., Reaven G. M. Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test. Diabetologia. 1994 Aug;37(8):843–845. doi: 10.1007/BF00404344. [DOI] [PubMed] [Google Scholar]
  30. Permutt M. A., Chiu K. C., Tanizawa Y. Glucokinase and NIDDM. A candidate gene that paid off. Diabetes. 1992 Nov;41(11):1367–1372. doi: 10.2337/diab.41.11.1367. [DOI] [PubMed] [Google Scholar]
  31. Perna A. F., Fadda G. Z., Massry S. G. Inhibition of phosphofructokinase activity in pancreatic islets in phosphate depletion. Miner Electrolyte Metab. 1991;17(1):8–11. [PubMed] [Google Scholar]
  32. Randle P. J. Glucokinase and candidate genes for type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1993 Apr;36(4):269–275. doi: 10.1007/BF00400227. [DOI] [PubMed] [Google Scholar]
  33. Rayman G., Clark P., Schneider A. E., Hales C. N. The first phase insulin response to intravenous glucose is highly reproducible. Diabetologia. 1990 Oct;33(10):631–634. doi: 10.1007/BF00400209. [DOI] [PubMed] [Google Scholar]
  34. Ristow M., Möhlig M., Rifai M., Schatz H., Feldmann K., Pfeiffer A. New isoniazid/ethionamide resistance gene mutation and screening for multidrug-resistant Mycobacterium tuberculosis strains. Lancet. 1995 Aug 19;346(8973):502–503. doi: 10.1016/s0140-6736(95)91351-3. [DOI] [PubMed] [Google Scholar]
  35. Sherman J. B., Raben N., Nicastri C., Argov Z., Nakajima H., Adams E. M., Eng C. M., Cowan T. M., Plotz P. H. Common mutations in the phosphofructokinase-M gene in Ashkenazi Jewish patients with glycogenesis VII--and their population frequency. Am J Hum Genet. 1994 Aug;55(2):305–313. [PMC free article] [PubMed] [Google Scholar]
  36. TARUI S., OKUNO G., IKURA Y., TANAKA T., SUDA M., NISHIKAWA M. PHOSPHOFRUCTOKINASE DEFICIENCY IN SKELETAL MUSCLE. A NEW TYPE OF GLYCOGENOSIS. Biochem Biophys Res Commun. 1965 May 3;19:517–523. doi: 10.1016/0006-291x(65)90156-7. [DOI] [PubMed] [Google Scholar]
  37. Taylor S. I., Accili D., Imai Y. Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM? Diabetes. 1994 Jun;43(6):735–740. doi: 10.2337/diab.43.6.735. [DOI] [PubMed] [Google Scholar]
  38. Temple R. C., Carrington C. A., Luzio S. D., Owens D. R., Schneider A. E., Sobey W. J., Hales C. N. Insulin deficiency in non-insulin-dependent diabetes. Lancet. 1989 Feb 11;1(8633):293–295. doi: 10.1016/s0140-6736(89)91306-8. [DOI] [PubMed] [Google Scholar]
  39. Van Schaftingen E. Glycolysis revisited. Diabetologia. 1993 Jul;36(7):581–588. doi: 10.1007/BF00404065. [DOI] [PubMed] [Google Scholar]
  40. Vora S., Davidson M., Seaman C., Miranda A. F., Noble N. A., Tanaka K. R., Frenkel E. P., Dimauro S. Heterogeneity of the molecular lesions in inherited phosphofructokinase deficiency. J Clin Invest. 1983 Dec;72(6):1995–2006. doi: 10.1172/JCI111164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Vorgerd M., Karitzky J., Ristow M., Van Schaftingen E., Tegenthoff M., Jerusalem F., Malin J. P. Muscle phosphofructokinase deficiency in two generations. J Neurol Sci. 1996 Sep 15;141(1-2):95–99. doi: 10.1016/0022-510x(96)00131-1. [DOI] [PubMed] [Google Scholar]
  42. Yaney G. C., Schultz V., Cunningham B. A., Dunaway G. A., Corkey B. E., Tornheim K. Phosphofructokinase isozymes in pancreatic islets and clonal beta-cells (INS-1). Diabetes. 1995 Nov;44(11):1285–1289. doi: 10.2337/diab.44.11.1285. [DOI] [PubMed] [Google Scholar]
  43. Yoshioka N., Kuzuya T., Matsuda A., Taniguchi M., Iwamoto Y. Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1988 Jun;31(6):355–360. doi: 10.1007/BF02341503. [DOI] [PubMed] [Google Scholar]
  44. Zhou X. J., Fadda G. Z., Perna A. F., Massry S. G. Phosphate depletion impairs insulin secretion by pancreatic islets. Kidney Int. 1991 Jan;39(1):120–128. doi: 10.1038/ki.1991.15. [DOI] [PubMed] [Google Scholar]
  45. Zouali H., Velho G., Froguel P. Polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med. 1993 May 27;328(21):1568–1569. doi: 10.1056/NEJM199305273282113. [DOI] [PubMed] [Google Scholar]
  46. t Hart L. M., Lemkes H. H., Heine R. J., Stolk R. P., Feskens E. J., Jansen J. J., van der Does F. E., Grobbee D. E., Kromhout D., van den Ouweland J. M. Prevalence of maternally inherited diabetes and deafness in diabetic populations in The Netherlands. Diabetologia. 1994 Nov;37(11):1169–1170. doi: 10.1007/BF00418385. [DOI] [PubMed] [Google Scholar]
  47. van den Ouweland J. M., Lemkes H. H., Ruitenbeek W., Sandkuijl L. A., de Vijlder M. F., Struyvenberg P. A., van de Kamp J. J., Maassen J. A. Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet. 1992 Aug;1(5):368–371. doi: 10.1038/ng0892-368. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES